318 related articles for article (PubMed ID: 11563629)
1. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.
Uchihara T; Fujigasaki H; Koyano S; Nakamura A; Yagishita S; Iwabuchi K
Acta Neuropathol; 2001 Aug; 102(2):149-52. PubMed ID: 11563629
[TBL] [Abstract][Full Text] [Related]
2. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
[TBL] [Abstract][Full Text] [Related]
3. Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content.
Takahashi J; Fujigasaki H; Zander C; El Hachimi KH; Stevanin G; Dürr A; Lebre AS; Yvert G; Trottier Y; de Thé H; Hauw JJ; Duyckaerts C; Brice A
Brain; 2002 Jul; 125(Pt 7):1534-43. PubMed ID: 12077003
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease.
Takahashi J; Tanaka J; Arai K; Funata N; Hattori T; Fukuda T; Fujigasaki H; Uchihara T
J Neuropathol Exp Neurol; 2001 Apr; 60(4):369-76. PubMed ID: 11305872
[TBL] [Abstract][Full Text] [Related]
5. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
[TBL] [Abstract][Full Text] [Related]
6. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.
Nozaki K; Onodera O; Takano H; Tsuji S
Neuroreport; 2001 Oct; 12(15):3357-64. PubMed ID: 11711886
[TBL] [Abstract][Full Text] [Related]
7. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study.
Koyano S; Uchihara T; Fujigasaki H; Nakamura A; Yagishita S; Iwabuchi K
Neurosci Lett; 1999 Oct; 273(2):117-20. PubMed ID: 10505630
[TBL] [Abstract][Full Text] [Related]
8. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.
Evert BO; Vogt IR; Kindermann C; Ozimek L; de Vos RA; Brunt ER; Schmitt I; Klockgether T; Wüllner U
J Neurosci; 2001 Aug; 21(15):5389-96. PubMed ID: 11466410
[TBL] [Abstract][Full Text] [Related]
10. An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients.
Schmidt T; Landwehrmeyer GB; Schmitt I; Trottier Y; Auburger G; Laccone F; Klockgether T; Völpel M; Epplen JT; Schöls L; Riess O
Brain Pathol; 1998 Oct; 8(4):669-79. PubMed ID: 9804376
[TBL] [Abstract][Full Text] [Related]
11. Nuclear inclusions in spinocerebellar ataxia type 1.
Duyckaerts C; Dürr A; Cancel G; Brice A
Acta Neuropathol; 1999 Feb; 97(2):201-7. PubMed ID: 9928833
[TBL] [Abstract][Full Text] [Related]
12. Preferential recruitment of ataxin-3 independent of expanded polyglutamine: an immunohistochemical study on Marinesco bodies.
Fujigasaki H; Uchihara T; Takahashi J; Matsushita H; Nakamura A; Koyano S; Iwabuchi K; Hirai S; Mizusawa H
J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):518-20. PubMed ID: 11561037
[TBL] [Abstract][Full Text] [Related]
13. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.
Perez MK; Paulson HL; Pendse SJ; Saionz SJ; Bonini NM; Pittman RN
J Cell Biol; 1998 Dec; 143(6):1457-70. PubMed ID: 9852144
[TBL] [Abstract][Full Text] [Related]
14. Misfolding promotes the ubiquitination of polyglutamine-expanded ataxin-3, the defective gene product in SCA3/MJD.
Jana NR; Nukina N
Neurotox Res; 2004; 6(7-8):523-33. PubMed ID: 15639784
[TBL] [Abstract][Full Text] [Related]
15. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.
Bichelmeier U; Schmidt T; Hübener J; Boy J; Rüttiger L; Häbig K; Poths S; Bonin M; Knipper M; Schmidt WJ; Wilbertz J; Wolburg H; Laccone F; Riess O
J Neurosci; 2007 Jul; 27(28):7418-28. PubMed ID: 17626202
[TBL] [Abstract][Full Text] [Related]
16. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.
Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT
Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986
[TBL] [Abstract][Full Text] [Related]
17. Neuropathological staging of spinocerebellar ataxia type 2 by semiquantitative 1C2-positive neuron typing. Nuclear translocation of cytoplasmic 1C2 underlies disease progression of spinocerebellar ataxia type 2.
Koyano S; Yagishita S; Kuroiwa Y; Tanaka F; Uchihara T
Brain Pathol; 2014 Nov; 24(6):599-606. PubMed ID: 24674145
[TBL] [Abstract][Full Text] [Related]
18. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group.
Pujana MA; Corral J; Gratacòs M; Combarros O; Berciano J; Genís D; Banchs I; Estivill X; Volpini V
Hum Genet; 1999 Jun; 104(6):516-22. PubMed ID: 10453742
[TBL] [Abstract][Full Text] [Related]
19. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions.
Holmberg M; Duyckaerts C; Dürr A; Cancel G; Gourfinkel-An I; Damier P; Faucheux B; Trottier Y; Hirsch EC; Agid Y; Brice A
Hum Mol Genet; 1998 May; 7(5):913-8. PubMed ID: 9536097
[TBL] [Abstract][Full Text] [Related]
20. Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease.
Lieberman AP; Trojanowski JQ; Leonard DG; Chen KL; Barnett JL; Leverenz JB; Bird TD; Robitaille Y; Malandrini A; Fischbeck KH
Ann Neurol; 1999 Aug; 46(2):271-3. PubMed ID: 10443897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
